80

DAFTAR PUSTAKA

Anonim, 2008, Iso farmakoterapi, 288-294, PT.ISFI Penerbitan, Jakarta.

American Diabetes Association (ADA), 2011, Standards of Medical Care in

Diabetes,- 2011, Diabetes Care, 34(Suppl 1): S11-S61.

American Psychiatric Association, 2000, Diagnostic Criteria from DSM-IV-TR,

Washington DC.

Bhugra, D., 2005, The global prevalence of schizophrenia, PLoS Med, 2(5): 151

Bourke, J., & Castle, M., 2008, The Psychotic Disorder; Schizophrenia cit
Horton-Szar, e.d., Crash Sourse- Pshychiatry, Mosby Elsevier, Philadelphia,
3rd ED, p.105-8

Bushe, C., Holt, R., 2004, Prevalence of Diabetes and Impaired Glucose
Tolerance in Patient with Skizophrenia, British Journal of Psychiatry, 84
(suppl. 47): s67-s71.

Cardno, A.G, & Gottesman II, 2000, Twin studies of schizophrenia: from bow-
and-arrow concordances to star wars Mx and functional genomics, American
Journal of Medical Genetics. Spring, 97(1): 12-17.

Castagna, L.G., 2011, Type II Diabetes in Children, J Psychology, 5: 1-10.

Crismon, M.l., Argo, T.R., & Buckley, P.F., in Schizophrenia, Dipiro, J.T.,
Talbert, R.L., Yee, G.C. Matzke, G.R., Wells, B.G., Posey, L.M., (Eds),
2008, Pharmacotherapy A Pathophysiologic Approach, seventh edition,
1009-1122, McGraw Hill, Medical Publishing Division, New York.

Dawe, G.S., Hwang, E.H., & Tan, C.H., 2009, Pathophysiology and Animal
Models of Schizophrenia, Ann Acad Med Singapore , 38 (5), 425-30.

Ebert, M.H., Loosen P.T., & Nurcombe, B., 2007, Current Diagnosis &
Treatment in Psychiatry, The McGraw-Hill Companies, Tennessee.

Gianfrancesco, F., White, R., Wang, R., & Nasrallah, H.A., 2003, Antipsychotic-
Induced Type 2 Diabetes: Evidence From a Large Health Plan Database,
Journal of Clinical Psychoparmacology, Vol 23, No 4.

Girgis, R.R., Javitch, J.A., & Lieberman, J.A., 2008, Antipsychotic drug
Mechanism: Links Between Therapeutic Effect, Metabolik Side Effect and
Insulin Signaling Pathway, Molecular Psychiatry, 13, 918-929.

Haddad, P.M., 2004, Antipsychotics and Diabetes: Review of Non-Prospective

Data, British Journal of Psychiatry, 184(suppl. 47), 80-86.
 81

Halgin, R.P., Whitbourne, & Susan, K., 2010, Psikologi Abnormal: Perspektif
Klinis pada Gangguan Psikologis, Edisi 6, Buku 2, Salemba Humanika,
Jakarta.

Harrison, P.J., & Owen, M.J., 2003, Genes for Schizophrenia? Recent Finding and
Their Pathophysiological Implication. Lancet, 361: 417-19

Haupt, D.W., & Newcomer, J.W., 2001,Hyperglycemia and Antipsychotic

Medication, J Clin Psychiatry, 62(suppl 27):15-26.

Henderson, D.C., Nguyen, D.D., Copeland, P.M., Hayden, D.L., Borba, C.P.,
Louie, P.M., Freudenreich, O., Evins, E., Cather, C., & Goff, D.C., 2005,
Clozapine, Diabetes Mellitus, Hyperlipidemia, and Cardiovascular Risks and
Mortality: Results of a 10 Year Naturalistic Study, J Clin Psychiatry,
66:1116-1121.

Hor, K., & Taylor, M., 2010, Suicide and Schizophrenia: a Systematic Review of
Rates and Risk Factors, J Psychopharmacol, 24(4 Suppl): 81-90.

Ikawati, Z., 2011, Farmakoterapi Penyakit Sistem Syaraf Pusat, 249-282, Bursa
Ilmu, Jakarta.

Jeste, D.V. & Mueser, K.T., 2008, Clinical Handbook of Schizophrenia, Guilford
Press, New York.

Kaplan, H.,I., & Sadock, B.J., 1997, Sinopsis Psikiatri, Jilid 2, Binarupa Aksara,
Jakarta.

Kety S.S., Wender, P.H., & Jacobsen, B., 1994, Mental Illness in the Biological
and Adoptive Relatives of Schizophrenic Adoptees, Arch Gen Psychiatry,
51(6): 442-55.

Lean, M.E.J., & Pajonk, F-G., 2003, Patients on Atypikal Antipsychotic Drugs:
Another High-Risk Group for Type 2 Diabetes, Diabetes Care, Vol 26,
15897-1605.

Lindenmayer, J-P., Czobor, P., Volavka, J., Citrome, L., Sheitman, B., McEvoy,
J.B., Cooper, T.B., Chakos, & M., Lieberman, J.A., 2003, Changes in
Glucose and Cholesterol Levels in Patients With Skizophrenia Treated With
Typical or Atypical Antipsychotics, Am J Psychiatry, 160:290-296.

Lipscombe, L.L., Levesque, L., Gruneir, A., Fischer, H.D, Juurlink, D.N, Gill,
S.S., Hermmann, N., Hux, J.E., Anderson, G.M, & Rochon, P.A., , 2009,
Antipsychotic Drugs and Hyperglycemia in Older Patients With Diabetes,
Arch Intern Med, 169914: 1282-1289.

Maslim, R., 2003, Buku Saku Diagnosis Gangguan Jiwa Rujukan Ringkas dari
PPDGJ III, Nuh Jaya, Jakarta.
 82

Medscape, Schizophrenia, 2013, http://emedicine.medscape.com/article/288259-

medication, 5 Juni 2013.

National Institue of Health (NIH), 2013, Glucose Test-Blood,

http://www.nlm.nih.gov/medLineplus/ency/article/003482.htm, 6 Juni 2013

National Institute of Mental Health (NIMH), 2013, Schizophrenia,

http://www.nimh.nih.gov/health/publications/schizophrenia/nimh-
schizophrenia-booklet.pdf, 5 Juni 2013.

Nevid, J.S., Rathus, S.A., & Greene, B., 2005, Psikologi Abnormal, Edisi kelima,
Jilid satu, diterjemahkan oleh Tim Fakultas Psikologi Universitas Indonesia ,
Erlangga, Jakarta.

Newcomer, J.W., Haupt, D.W., Fucetola, R.,Melson, A.K., Schweiger, J.A.,

Cooper, B.P., & Selke, G., Abnormalitoes in Glucose Regulation During
Antipsychotic Treatment of Schizophrenia, Arch Gen Psychiatry, 2002,
59:337-345.

Octaviana, M.N., 2009, Evaluasi Rejimen Obat Scizophrenia pada Unit Rawat
Jalan dan Rawat Inap Setelah Uji Coba INA-DRG di Rumah Sakit Jiwa Dr.
Soeharto Heerdjan Jakarta, Tesis, Magister Ilmu Kefarmasian Universitas
Indonesia, Depok.

Seeman, 2004, Atypical antipsychotics : mechanism of action, Canadian J

Psychiatry, 47:27-38.

Semiun, Y., 2006, OFM Kesehatan Mental 3, 20-104, Kanisius, Yogyakarta.

Sinaga, B.R., 2007, Skizofrenia dan Diagnosis Banding, 4-16, 52-3,70-6. FKUI
Jakarta.

Shen, W.W., 1999, A history of antypsychotic drug development, Comprehensive

Psychiatry, 40(6):407-14

Stahl, S.M., 1999, Antipsychotic Polypharmacy: I therapeutic option or dirty little

secret ?, Journal of Clinical Psychiatry, 60:425-426.

Stuart & Sundeen, 1995, Principles and Practice of Psychiatric Nursing, 5th ed,
Mosby, St Louis.

Stuart, G.W., & Sundeen, S.J.,1998, Buku Saku Keperawatan Jiwa. ED 3, EGC,
Jakarta.

Teff, K.L., & Kim, S.F., 2011, Atypical Antipsychotic and Neural Regulation of
Food Intake and Peripheral Metabolism, Phsysiology and Behavior, 104:
590-598.
 83

Tharyan, P., & Adams, C.E., 2005, Electroconvulsive Therapy for Schizophrenia,
Cochrane Database of Sistematic Reviews, Issue 2. Art. No : CD000076
Veague, H.B., 2007, Psychological Disorder: Schizophrenia, Edisi 1, 75-8,
Infobase publishing, New York.

Wiramihardja, S.A., 2007, Pengantar Psikologi Abnormal, 134, Refika Aditama,

Bandung.

Woo, V., Harris, S.B., & Houlden, R.L., 2005, Canadian Diabetese Association
Position Paper: Antisychotic Medication and Associated Risk of Weight Gain
and Diabetes, Canadian Journal of Diabetes, 29(2): 111-112.